Genius Moodroller

30% Reduction in social anxiety, such as in high-pressure situations.
25% Decrease in cortisol levels - stress hormone.
25% Calmer heart rate during stressful events.

*Clinical Trial: Charisma was tested in a clinical study trial on 150 healthy adults using the Trier Social Stress Test (TSST) to assess its impact on social anxiety.

30% Reduction in social anxiety, such as in high-pressure situations.
25% Decrease in cortisol levels - stress hormone.
25% Calmer heart rate during stressful events.

*Clinical Trial: Charisma was tested in a clinical study trial on 150 healthy adults using the Trier Social Stress Test (TSST) to assess its impact on social anxiety.

25% Immediate reduction in stress levels, and increased calmness.
10% Decrease in blood pressure, with a 30% faster return to baseline.
10% Reduction in stress-related immune and hormone responses.

*Clinical Trial: Chill was tested in a clinical study trial on 90 healthy adults where participants completed validated multi-tasking framework designed to induce acute stress, simulating the cognitive overload of a busy workday or high-pressure environment.

25% Immediate reduction in stress levels, and increased calmness.
10% Decrease in blood pressure, with a 30% faster return to baseline.
10% Reduction in stress-related immune and hormone responses.

*Clinical Trial: Chill was tested in a clinical study trial on 90 healthy adults where participants completed validated multi-tasking framework designed to induce acute stress, simulating the cognitive overload of a busy workday or high-pressure environment.

90% Felt it uplift their spirit with an instantaneous mood lift.
88% Experienced a sense of contentment.
80% Felt invigorated and experienced a reduction in negative emotions.

*Consumer Trial: Euphoric was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

90% Felt it uplift their spirit with an instantaneous mood lift.
88% Experienced a sense of contentment.
80% Felt invigorated and experienced a reduction in negative emotions.

*Consumer Trial: Euphoric was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

90% Felt more awake and alert after use.
88% Experienced relief from congestion or feeling unwell.
86% Reported improved focus and readiness to take on the day.

*Consumer Trial: Fit was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.

90% Felt more awake and alert after use.
88% Experienced relief from congestion or feeling unwell.
86% Reported improved focus and readiness to take on the day.

*Consumer Trial: Fit was tested in a two-week consumer user trial with 50 healthy adults, ages 18-60.